BioNTech names KPMG as independent auditor for FY2027
BNTX•KPMG named as independent auditor for FY2027
BioNTech named KPMG as independent auditor for the financial year ending Dec. 31, 2027, pending shareholder election at its AGM.
The audit committee ran a competitive tender process, then recommended KPMG; the supervisory board will put the appointment to shareholders.
The company is not subject to mandatory auditor rotation, yet opted to reassess its external audit arrangements as a governance measure.
